Creative Touch Permanent Makeup and Aesthetics

The treatment context for hyaluronic acid is unusual in that HA itself is both the substance being restored and the active component in several of Creative Touch’s treatments. Understanding what HA does in the dermis, and why its loss matters beyond aesthetics, frames every injectable, topical, and supplementary HA intervention more precisely than the standard “hydration and volume” narrative allows.

Injectable HA: Mechanical Restoration First

The most clinically significant insight from HA research is that injected cross-linked HA restores collagen synthesis not by delivering a biological signal directly, but by restoring the mechanical tension that fibroblasts require to remain biosynthetically active. The volume effect is visible; the fibroblast reactivation is the mechanism that produces durable structural improvement. This distinction matters for how injectable treatments are positioned to clients: skin boosters and dermal fillers are not simply filling spaces but re-establishing the matrix environment that drives ongoing collagen production.

Skin boosters (non-crosslinked or lightly crosslinked HA) target mid-dermal hydration and ground substance restoration. Their primary indication is diffuse quality decline – skin that has lost resilience, suppleness, and the ability to recover quickly – rather than discrete volumetric loss. The biopsy evidence confirming procollagen I and III upregulation following injected HA applies most directly here: in well-hydrated skin with intact ground substance, fibroblasts remain mechanically stimulated and continue contributing to the collagen matrix. For clients with UV-accumulated HA loss or perimenopausal ground substance depletion, skin boosters address the fibroblast quiescence mechanism at its source.

Dermal fillers and Hyaluronic acid lip fillers operate through related but distinct mechanisms, with volumetric restoration as the primary indication alongside mechanical matrix effects. These are covered in their dedicated treatment entities.

Lumi-Pro Lips uses non-crosslinked HA specifically for lip tissue hydration and quality improvement rather than structural augmentation; the relevant mechanism is surface and submucosal hydration restoration rather than deep dermal mechanical signalling.

Protecting What’s There

Before discussing what injectable HA builds, it is worth noting what actively degrades it. Matrix metalloproteinases (MMPs), particularly hyaluronidase activity, continuously turn over dermal HA, and in inflamed, UV-damaged, or hormonally depleted tissue this degradation rate outpaces synthesis. Polynucleotides suppress MMP activity through NF-κB inhibition, reducing the enzymatic burden that degrades both HA and the collagen it scaffolds. For clients with significantly photoaged or inflammation-burdened dermis, polynucleotides as a preparatory or concurrent treatment reduce the rate at which injected HA is broken down, extending the effective window of mechanical stimulation and collagen response. This is the treatment logic applied to ground substance: reduce degradation first, then restore volume and tension.

Topical HA: Calibrated Expectations

Topical HA is effective for surface hydration but does not restore dermal ground substance. High molecular weight HA applied topically forms a hydrating film at the skin surface – genuine and useful for barrier comfort and transient plumping appearance, but not penetrating to the fibroblast layer where mechanosensing occurs. Low molecular weight HA penetrates further but carries a pro-inflammatory profile at the tissue level, making it a less straightforward recommendation for sensitised or barrier-compromised skin.

The realistic positioning for topical HA in a homecare protocol is surface comfort and hydration support between professional treatments, not a substitute for the dermal restoration that injectable delivery achieves. For clients asking whether their topical HA serum is “doing the same thing” as a skin booster, the honest answer is that they are working at different depths with different mechanisms.

Oral HA: A Supplementary Option

For clients interested in nutritional support for skin hydration, oral HA has a more developed evidence base than many widely marketed supplements. A 2023 double-blind RCT of 129 participants showed measurable hydration improvement and epidermal thickness increase at 12 weeks – effects attributed to intestinal HA receptor activation stimulating endogenous fibroblast synthesis rather than intact HA reaching the dermis directly. The trial pool remains limited, and this is supplementary support rather than a treatment-level intervention. For clients already investing in injectable protocols, oral HA is a reasonable adjunct to discuss alongside diet and skin-directed supplementation more broadly.

Treatment Pairings for Dermal HA Restoration

• Skin boosters + polynucleotides: Polynucleotides reduce MMP/hyaluronidase activity (Category B) before or alongside HA injection; injectable HA restores matrix tension and fibroblast mechanical signalling (Category A). Degradation slowed + synthesis environment restored.

• Skin boosters + iPRF: HA restores the matrix mechanical environment; iPRF delivers growth factors (PDGF, TGF-β1, IGF-1) that directly stimulate fibroblast procollagen synthesis in a now-mechanically activated cell population. The combination addresses ground substance and growth factor signalling concurrently.

• Skin boosters + RF microneedling: RF microneedling reverses fibroblast senescence and restores endogenous IGF-1 production; skin boosters restore the mechanosensing environment those reactivated fibroblasts require to translate growth factor signals into structural output. Particularly relevant for significantly aged or hormonally depleted skin where both fibroblast senescence and ground substance depletion are concurrent.

Cross-linking, Longevity, and Maintenance

Injected HA does not persist indefinitely because the body’s hyaluronidase enzyme continues to act on it – more slowly than on native HA, but persistently. Cross-linking is the engineering response to this problem: BDDE (1,4-butanediol diglycidyl ether), the most widely used cross-linking agent in licensed fillers, forms ether bonds between HA chains that physically obstruct hyaluronidase access to the glycosidic bonds it would otherwise cleave. The cross-linked material behaves like a gel rather than a free-floating polysaccharide, degrading from the surface inward rather than all at once.

The degree of cross-linking, alongside manufacturing technology, influences how long this resistance holds. Greater cross-linking density increases resistance to enzymatic breakdown, though the relationship is not strictly linear across all products – manufacturing platform matters as much as cross-linking degree in determining in vitro degradation kinetics. ^[4] What this means clinically is that different fillers within the HA family are not interchangeable: a lighter cross-linked skin booster restores ground substance differently from a highly cross-linked structural filler, and their respective clinical durations reflect those material differences.

The maintenance rationale follows directly from the turnover biology. Endogenous HA in the dermis is replaced on a cycle of roughly 24 hours; even the most robustly cross-linked injectable formulation will eventually be degraded, with the visible volumetric effect typically declining over six to eighteen months depending on product, placement, and individual metabolism. ^[3] This is not product failure – it is the biology of HA as a material. Setting expectations accordingly, and framing regular appointments as the normal cadence of working with a biologically active substance, gives clients a more accurate picture than “top-ups required.”

This ground substance depletion that cross-linked HA addresses is one of three converging dermal mechanisms in skin ageing – alongside net collagen loss and elastic fibre fragmentation – which is why volumetric restoration with HA is most effective when understood within that wider structural context rather than as an isolated hydration intervention.